Last reviewed · How we verify

pregabalin capsules — Competitive Intelligence Brief

pregabalin capsules (pregabalin capsules) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gabapentinoid; anticonvulsant; anxiolytic. Area: Neurology; Pain Management; Psychiatry.

marketed Gabapentinoid; anticonvulsant; anxiolytic Alpha-2-delta-1 subunit of voltage-gated calcium channels Neurology; Pain Management; Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

pregabalin capsules (pregabalin capsules) — AstraZeneca. Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
pregabalin capsules TARGET pregabalin capsules AstraZeneca marketed Gabapentinoid; anticonvulsant; anxiolytic Alpha-2-delta-1 subunit of voltage-gated calcium channels
Gabapentin Capsules Gabapentin Capsules EpiCept Corporation marketed Anticonvulsant; Gabapentinoid Alpha-2-delta-1 subunit of voltage-gated calcium channels
Standard dose gabapentin Standard dose gabapentin Mario Negri Institute for Pharmacological Research marketed Anticonvulsant; gabapentinoid Alpha-2-delta-1 subunit of voltage-gated calcium channels
Placebo matched with pregabalin Placebo matched with pregabalin Pfizer's Upjohn has merged with Mylan to form Viatris Inc. phase 3 Gabapentinoid Alpha-2-delta-1 subunit of voltage-gated calcium channels
Perioperative Pregabalin Perioperative Pregabalin McMaster University phase 3 Gabapentinoid; anticonvulsant; anxiolytic analgesic Alpha-2-delta-1 subunit of voltage-gated calcium channels
Pregabalin add-on therapy Pregabalin add-on therapy Pfizer's Upjohn has merged with Mylan to form Viatris Inc. phase 3 Gabapentinoid Alpha-2-delta-1 subunit of voltage-gated calcium channels
Neurontin gabapentin Generic (originally Parke-Davis/Pfizer) marketed Gabapentinoid (anticonvulsant/neuropathic pain agent) Large neutral amino acids transporter small subunit 1, Adenosine receptor A1, Alpha-2A adrenergic receptor 1993-12-30

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gabapentinoid; anticonvulsant; anxiolytic class)

  1. AstraZeneca · 1 drug in this class
  2. Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
  3. Hawler Medical University · 1 drug in this class
  4. Jiangsu HengRui Medicine Co., Ltd. · 1 drug in this class
  5. Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). pregabalin capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/pregabalin-capsules. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: